Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive neocortical damage in epilepsy.

Rebecca S N Liu1, Louis Lemieux, Gail S Bell

  • 1Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London, United Kingdom.

Annals of Neurology
|February 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is there already value in "Total Body PET" imaging in Neurology?

The British journal of radiology·2026
Same author

The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network.

European journal of nuclear medicine and molecular imaging·2026
Same author

Systematic review of pituitary gland and pituitary adenoma automatic segmentation techniques in magnetic resonance imaging.

Frontiers in radiology·2026
Same author

Inter-individual variability of neurotransmitter receptor and transporter density in the human brain.

Brain structure & function·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Clinical Perspectives on Using Remote Measurement Technology in Assessing Epilepsy, Multiple Sclerosis, and Depression: Delphi Study.

JMIR neurotechnology·2025
Same journal

Reply to "Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm".

Annals of neurology·2026
Same journal

Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm.

Annals of neurology·2026
Same journal

Imaging of Neurovascular Compression in Thoracic Outlet Syndrome.

Annals of neurology·2026
Same journal

Reply to "Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease".

Annals of neurology·2026
Same journal

Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease.

Annals of neurology·2026
Same journal

The Financial Value of an Academic Neurologist.

Annals of neurology·2026
See all related articles

Neocortical atrophy, or brain tissue loss, is common in epilepsy patients, affecting over half with chronic epilepsy. Age and multiple antiepileptic drugs increase this risk.

Area of Science:

  • Neurology
  • Neuroimaging
  • Epilepsy Research

Background:

  • Epilepsy is a chronic neurological disorder characterized by recurrent seizures.
  • Neocortical atrophy, a loss of brain tissue, is a potential consequence of epilepsy.
  • Understanding the patterns and risk factors of neocortical atrophy is crucial for patient management.

Purpose of the Study:

  • To investigate the incidence and patterns of neocortical atrophy in epilepsy.
  • To identify factors associated with the development of neocortical atrophy in epilepsy patients.
  • To compare neocortical changes in chronic epilepsy, newly diagnosed epilepsy, and control groups.

Main Methods:

  • Prospective, longitudinal follow-up study over 3.5 years.
  • Serial magnetic resonance imaging (MRI) scans analyzed using image subtraction.

Related Experiment Videos

  • Quantification of diffuse and focal neocortical volume loss with automated segmentation and a brain atlas.

    • Main Results:

    • New focal or generalized neocortical volume loss occurred in 54% of chronic epilepsy patients, 39% of newly diagnosed patients, and 24% of controls.
    • Patients with chronic epilepsy showed a significantly higher likelihood of developing neocortical atrophy compared to controls.
    • Age and exposure to multiple antiepileptic drugs were identified as risk factors for neocortical atrophy; seizure history was not a significant factor.

    Conclusions:

    • Focal and generalized neocortical atrophy is a common finding in chronic epilepsy, often widespread and not confined to the seizure focus.
    • Observed neocortical changes in controls may represent physiological aging.
    • The findings suggest that epilepsy-related brain changes may involve extensive neural networks.